Editorial update on emerging treatments of atopic dermatitis

被引：4
作者：
Ong, Peck Y. [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Div Clin Immunol & Allergy,Dept Pediat, Los Angeles, CA 90027 USA
来源：
EXPERT OPINION ON EMERGING DRUGS | 2012年 / 17卷 / 02期
关键词：
atopic dermatitis; IL-22; S; aureus; therapy; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL PEPTIDES; IL-22; KERATINOCYTES; IMMUNITY; SKIN;
D O I：
10.1517/14728214.2012.668884
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Various new agents are in the research pipeline for atopic dermatitis. These include IL-4 receptor antagonist, cis-urocanic acid, kappa-opiod receptor agonist, neurokinin receptor antagonist and antimicrobial peptide. The current review updates the status of these clinical trials and provides insight into other potential molecular targets including IL-22 and TLR-2.
引用
收藏
页码：129 / 133
页数：5
相关论文
共 20 条
  • [1] Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis
    Guttman-Yassky, Emma
    Lowes, Michelle A.
    Fuentes-Duculan, Judilyn
    Zaba, Lisa C.
    Cardinale, Irma
    Nograles, Kristine E.
    Khatcherian, Artemis
    Novitskaya, Inna
    Carucci, John A.
    Bergman, Reuven
    Krueger, James G.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (10) : 7420 - 7427
  • [2] Dilute Bleach Baths for Staphylococcus aureus Colonization in Atopic Dermatitis to Decrease Disease Severity
    Huang, Jennifer T.
    Rademaker, Alfred
    Paller, Amy S.
    [J]. ARCHIVES OF DERMATOLOGY, 2011, 147 (02) : 246 - 247
  • [3] MECHANISMS OF DISEASE Filaggrin Mutations Associated with Skin and Allergic Diseases
    Irvine, Alan D.
    McLean, W. H. Irwin
    Leung, Donald Y. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14) : 1315 - 1327
  • [4] β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
    Jansen, Patrick A. M.
    Rodijk-Olthuis, Diana
    Hollox, Edward J.
    Kamsteeg, Marijke
    Tjabringa, Geuranne S.
    de Jongh, Gys J.
    van Vlijmen-Willems, Ivonne M. J. J.
    Bergboer, Judith G. M.
    van Rossum, Michelle M.
    de Jong, Elke M. G. J.
    den Heijer, Martin
    Evers, Andrea W. M.
    Bergers, Mieke
    Armour, John A. L.
    Zeeuwen, Patrick L. J. M.
    Schalkwijk, Joost
    [J]. PLOS ONE, 2009, 4 (03):
  • [5] Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus
    Miajlovic, Helen
    Fallon, Padraic G.
    Irvine, Alan D.
    Foster, Timothy J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (06) : 1184 - U182
  • [6] Staphylococcus aureus susceptibility to innate antimicrobial peptides, β-defensins and CAP18, expressed by human keratinocytes
    Midorikawa, K
    Ouhara, K
    Komatsuzawa, H
    Kawai, T
    Yamada, S
    Fujiwara, T
    Yamazaki, K
    Sayama, K
    Taubman, MA
    Kurihara, H
    Hashimoto, K
    Sugai, M
    [J]. INFECTION AND IMMUNITY, 2003, 71 (07) : 3730 - 3739
  • [7] Miller DW, 2011, J DRUGS DERMATOL, V10, P531
  • [8] Immunity against Staphylococcus aureus cutaneous infections
    Miller, Lloyd S.
    Cho, John S.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2011, 11 (08) : 505 - 518
  • [9] Staphylococcal α-Toxin Induces a Higher T Cell Proliferation and Interleukin-31 in Atopic Dermatitis
    Niebuhr, Margarete
    Mamerow, Diana
    Heratizadeh, Annice
    Satzger, Imke
    Werfel, Thomas
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2011, 156 (04) : 412 - 415
  • [10] Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients
    Niebuhr, Margarete
    Heratizadeh, Annice
    Wichmann, Katja
    Satzger, Imke
    Werfel, Thomas
    [J]. EXPERIMENTAL DERMATOLOGY, 2011, 20 (06) : 468 - 472
12